Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.

Stem cell research | 2019

Leucine rich repeat kinase 2 (LRRK2) is the causative gene for autosomal-dominant familial forms of Parkinson's disease (PD). Here, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood mononuclear cells of a female patient with LRRK2 c.4111A > G (p.I1371V) mutation by using the Sendai-virus delivery system. The resulting iPSCs had a normal karyotype. The iPSCs also showed pluripotency confirmed by immunofluorescent staining and differentiated into the three germ layers in vivo. This cellular model will provide a platform for studying the role of LRRK2 in the disease process.

Pubmed ID: 31029016 RIS Download

Additional research tools detected in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BD Biosciences (tool)

RRID:SCR_013311

An Antibody supplier

View all literature mentions

Sox2 (antibody)

RRID:AB_1645334

This monoclonal targets Sox2

View all literature mentions

Mouse IgG3, k Isotype Control, Alexa Fluor 647 Conjugated, Clone J606 (antibody)

RRID:AB_2034029

This monoclonal targets Mouse IgG3 k Isotype Control Alexa Fluor 647 Clone J606

View all literature mentions

Oct3/4 (antibody)

RRID:AB_1645331

This monoclonal targets Oct3/4

View all literature mentions